Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes

NCT01464099 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: insulin aspart
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S